Actionable news
0
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

Bristol-Myers Squibb’s Bad News Buoys Merck

Review | Preview

Cancer patients and Bristol-Myers Squibb investors got dismal news on Friday, when the pharmaceutical developer said its blockbuster drug Opdivo hadn’t outdone chemotherapy in...


More